SCHEMBL2960039

SCHEMBL2960039

Cc1cc(-c2cccc3ccccc23)c2c(c1Br)CC=C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP2A6 P11509 1/20 0.35
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34
CA9 Q16790 3/20 0.34
BRD4 O60885 1/20 0.34
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
MAPT P10636 1/20 0.33
ACHE P22303 1/20 0.33
SLC6A2 P23975 1/20 0.33
AHR P35869 1/20 0.33
HTR1A P08908 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975589 0.89 ALDH1A1 (0.36) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2960984 0.82 NUDT1 (0.30) MAOAMAOB
SCHEMBL2967594 0.79 MAOA (0.35) ALDH1A1CYP2A6MAOAMAOBMAPK1
SCHEMBL2974077 0.78 CA12 (0.34) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2959810 0.77 DHFR (0.36) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2975183 0.77 DHFR (0.36) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2974770 0.77 DHFR (0.36) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2973616 0.77 DHFR (0.36) ALDH1A1CYP1A2HPGDHSD17B10CYP2A6
SCHEMBL2971058 0.77 CYP1A2 (0.36) ALDH1A1CYP1A2HPGDHSD17B10CA12
SCHEMBL2965041 0.76 MAOA (0.33) ALDH1A1CYP1A2CYP2A6CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 ALDH1A1 4332/4885CYP1A2 2409/4885HPGD 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.